International registry of robot-assisted minimally invasive surgery for gastric cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational international registry, led from The Chinese University of Hong Kong, collects standardized perioperative and postoperative data on patients undergoing robot-assisted minimally invasive gastrectomy (RAMIG). It aims to harmonize definitions of outcomes so results can be compared across centers, capture variations in surgical technique, and quantify the learning curve for surgeons adopting RAMIG. Data elements include patient characteristics, surgical details, complications, oncologic metrics, and hospital stay. Aggregated results will be used to inform safer and more effective implementation of RAMIG worldwide.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All gastric cancer patients undergoing RAMIG in a center

Exclusion Criteria:

* No

Where it's running

• The Chinese University of Hong Kong, Shatin, HK
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Shannon Melissa CHAN, MBChB, FRCSEd, FHKAM (Surgery) — Chinese University of Hong Kong
• Study coordinator: Shannon Melissa CHAN, MBChB, FRCSEd, FHKAM (Surgery)
• Email: shannonchan@surgery.cuhk.edu.hk
• Phone: +852 3505 2956

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Paclitaxel given inside the abdomen with systemic therapy for GI cancers with peritoneal spread

  This phase II study tests a combination of intraperitoneal and systemic chemotherapy (paclitaxel) in adults with digestive tract cancers that have spread to the peritoneum.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07795749

• TAIC FOLFOX for unresectable gastric and gastroesophageal junction cancer

  This study tests a combination of TAIC and FOLFOX chemotherapy to see if it helps adults with unresectable gastric cancer or gastroesophageal junction adenocarcinoma live longer and feel better.

  Recruiting Phase 2 Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Beijing · NCT07655024

• AI-assisted T-staging for gastric cancer with radiology guidance

  This study tests whether the TRACE AI system helps radiologists more accurately stage gastric cancer on CT scans.

  Recruiting Liaoning Cancer Hospital & Institute · Shenyang, Liaoning · NCT07651644

• Exercise training after upper gastrointestinal cancer surgery

  This trial tests whether high-intensity interval training or low-intensity aerobic training after curative surgery helps people recover better than usual care.

  Recruiting Kansai Medical University · Hirakata, Osaka and 1 other locations · NCT07561840

• Gastric cancer characteristics and care patterns in Algeria

  This project collects medical records and short interviews to describe who has gastric cancer and how they are diagnosed and treated at Algerian oncology centers.

  Recruiting Société Algérienne de Formation et Recherche en Oncologie · Algiers, Algeria and 14 other locations · NCT07481110

• DeepComp: AI prediction of complications after stomach cancer surgery

  This project will try an AI tool called DeepComp to predict which adults with gastric adenocarcinoma scheduled for curative stomach surgery are at high risk of moderate-to-severe postoperative complications using routine preoperative CT scans and clinical data.

  Recruiting Hebei Medical University · Shijiazhuang, None Selected · NCT07401173

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.